Titanium dioxide (TiO2) has long been marketed as an effective antimicrobial technology. However, its recent re-classification as possibly carcinogenic raises questions about TiO2's potential impact on both consumer and manufacturer safety.
In an article for Pitture e Vernici European Coatings, Microban International’s Dr. Ivan Ong, Vice President of Research and Development, and Tara Conley, Director of Regulatory Affairs, explore the potential consequences of using TiO2 and why the industry should consider safer alternative antimicrobial technologies.
